BB
Beta Bionics, Inc.
BBNX · NASDAQ
$21.89 +2.39% (+$0.51)
1M +14.91%
Market Cap $964.1M
P/E Ratio -
Div. Yield -
ROE 26.30%
Piotroski F-Score Weak
2/9Valuation
29 /100
Expensive P/B 3.76x
P/S 8.10x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 180.73%
Rev. growth 724.29%
FCF growth N/A
Profitability
20 /100
Weak Net margin 61.32%
Op. margin 69.75%
FCF margin 51.60%
Quality
5 /100
Poor ROE 26.30%
ROA 24.96%
Asset turnover 0.41x
Debt
100 /100
Low Current ratio 8.88x
Debt/Equity 0.03x
Net debt/EBITDA N/A
Stability
15 /100
Unstable Rev. volatility 3,672.88%
EPS volatility 41.24%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o BBNX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Sean T. Saint
Employees
422
Headquarters
Irvine
Nadchodzące wydarzenia
27 PAŹ
Earnings
Upcoming earnings report